Simply Managing Complex Data
SmartGene services to be used for the local detection of SARS-CoV-2 variants and national surveillance across France.
SmartGene's Bacteria Module is the perfect complement to the Applied Biosystems SeqStudio™ Genetic Analyzer.
Genetic analyses of SARS-CoV-2 and other Coronaviridae will have an increasingly important role to play, both in the current fight against COVID-19 and in preventing future epidemics of Coronaviridae.
SmartGene announces a clinical research collaboration with France's Centre of Excellence for the study and treatment of hepatitis viruses at the Virology Laboratory and National Reference Center for Viral Hepatitis B, C, and delta at Hospital Henri Mondor, University Paris-Est, Paris, France.
The IDNS Fungi 25-28S Reference Database has been reconfigured to improve coverage and species representation.
SmartGene receives certification of compatibility regarding the requirements of Title 21 Part 11 of the US Code of Federal Regulations.
Professor Anne-Geneviève Marcelin of Pitié-Salpêtrière Hospital Sorbonne, Paris, France presented the findings of a study based on data collected and analyzed using tools and search algorithms which SmartGene has made available for this purpose: Epidemiological study of Doravirine associated resistance mutations in HIV-1-infected treatment-naïve patients from two large databases in France and Italy.
With the release of version 5.3, SmartGene has applications available for HIV, Microbiome 16S, and HCV.
Following a successful notification to Swissmedic, the Swiss Agency for Therapeutic Products, SmartGene announces that the SmartGene Service Modules for HIV, HCV, Bacteria, Fungi, and HLA have obtained CE-IVD labeling.
Order by Supreme Court of the United States confirms SmartGene’s success invalidating patents which threatened the practice of personalized medicine.
Poster presented at the Medical Biodefense Conference in Munich, Germany.
SmartGene becomes an official Service Provider to the Public Hospital Laboratories AP-HP in Paris, France.
SmartGene Inc. announces the availability of curated reference databases to aid in sequence-based identification of Nocardia species.
SmartGene and the Institute of Medical Microbiology, University of Zurich expand their collaboration to address the sequence-based validation of mass spectrometry platforms for clinical microbiology.
SmartGene's Services for faster, more precise identification of Bacteria and Fungi to be used by the Johns Hopkins Hospital.
SmartGene has recently signed a contract to develop a data-analysis and data-management system dedicated to the typing of Campylobacter species as part of a European Union Consortium project called BIOTRACER.
SmartGene Inc. and LabCorp enter into a collaboration for faster, more precise identification of Bacteria and Fungi by sequence analysis.